Dr. Hemlata Wadhwani Bhatia is a highly respected geneticist, pediatric specialist, and healthcare leader who currently serves as Vice President—Genomics at Agilus Diagnostics, one of India’s largest and most advanced diagnostic services networks driving precision healthcare and genomic innovation. In this strategic role, she leads the company’s genomics division—focusing on developing and scaling advanced genomic testing solutions that support early detection, personalized treatment planning, and disease-monitoring strategies across clinical domains such as oncology, rare diseases, and reproductive and inherited disorders—thereby transforming molecular insights into meaningful patient-centric outcomes.

Dr. Bhatia’s academic and clinical foundation is rooted in rigorous pediatric and genetics training. She earned her MBBS from Maulana Azad Medical College, Delhi, followed by a Diploma in Child Health (DCH) and DNB (Paediatrics), and went on to specialize with a Fellowship in Medical Genetics as well as a Fellowship in Rare Disorders from leading institutions in India and Europe. This multidisciplinary grounding equips her with deep expertise in dysmorphology, pediatric and neonatal genetics, metabolic and reproductive genetics, cancer genomics, and predictive and preventive genomic care.

Prior to her genomics leadership role at Agilus Diagnostics, Dr. Bhatia built an extensive clinical and academic portfolio, serving as a principal consultant in medical genetics at top multi-specialty hospitals in Delhi and as a senior faculty and unit head involved in genetic counseling, prenatal and neonatal genetic diagnosis, and multi-system disorder evaluation. She has also served on expert committees, including the genetic and rare diseases core committee of the Indian Academy of Pediatrics, highlighting her broader influence on clinical practice standards and professional knowledge in genetics.

At Agilus, Dr. Bhatia champions precision diagnostics and next-generation molecular tools—including circulating tumor DNA (ctDNA) evaluation and other high-resolution genomic assays—as part of the organization’s commitment to precision oncology, rare disease pathways, and personalized medicine. Her leadership reflects a mission to bring advanced genomic insights into routine clinical practice, shorten diagnostic journeys, and enable tailored care plans that improve both patient outcomes and clinician decision-making.

Through her blend of scientific expertise, clinical acumen, and strategic vision in genomics, Dr. Hemlata Wadhwani Bhatia continues to elevate the role of genomic diagnostics within India’s healthcare ecosystem, bridging cutting-edge molecular science with real-world clinical impact.